Clinical Trial Update: The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial assesses dosimetry, safety, and diagnostic efficacy of the radiotracer 68Ga-FC516 in healthy adults and prostate cancer patients. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-FC516 (Gallium-68 labeled FC516 radiopharmaceutical)

Snippet

Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. | Conditions: Healthy Adult, Prostate Cancer | EARLY_Phase 1 | Status: RECRUITING